Skip to main content

Table 2 Information on the overlapping DEGs screened from the datasets

From: Integrated bioinformatics analysis for the screening of hub genes and therapeutic drugs in ovarian cancer

DEGs

Gene name

Upregulated (114)

WHSC1, VEGFA, TYMS, TSTA3, TPI1, TPD52L2, TOP2A, TNNT1, TMPRSS4, TIMELESS, C20orf24, TBC1D7, TACC3, STC2, SORT1, BOLA2, SLC52A2, SLC4A11, SLC39A4, SLC38A1, SLC2A1, SLC19A1, SHMT2, SCRIB, SAC3D1, S100A2, RRM2, RNASEH2A, RACGAP1, PXDN, PUF60, PTTG1, PSAT1, PPP1R14B, PIK3R3, PBK, OVOL2, NR2F6, NOV, NDUFB9, NDC80, NCAPG, MYCL, MUC16, MT1F, MRPS15, MRPL12, MLF2, MCM4, MCAM, MAL, LSM4, LPCAT1, C1orf186, LAPTM4B, KLK8, KLK7, KLK6, KLHL14, KIF4A, KIF11, KIAA0101, ISG15, IRAK1, IDH2, HN1, HMGB3, HMGA1, H2AFX, GPSM2, FOXM1, FGF18, FEN1, FDPS, ESRP1, EPT1, ENO1, E2F8, DYRK2, DTL, DSC2, DPP3, DHCR24, DGAT1, DDX39A, DBN1, CYC1, CTPS1, CRABP2, COPE, COL4A1, CLPTM1L, CLDN3, CHD7, CDH6, CDCA3, CDC20, CD47, CCNE1, CCNB2, C9orf16, C1orf106, BUB1B, BOLA2B, BIRC5, BAK1, AURKAIP1, ATP6V1B1, ASS1, ARL4C, ARF3, APOA1, AIF1L, ABHD11

Downregulated (57)

ZEB2, ZBTB20, WHAMMP2, WHAMMP3, WDR17, TLE4, THBD, TFPI, SYTL3, SNCAIP, SMIM14, SLC4A4, SCD5, RUNX1T1, RUNDC3B, RNASE4, PTPN13, PRKAR1A, PLCL2, PIP5K1B, PDK4, PDGFRA, NDNF, NBEA, N4BP2L2, N4BP2L1, MPDZ, MITF, MEF2C, MAF, FAM153A, FAM153B, FAM153C, KLHDC1, KLF2, KAT2B, KANSL1L, ITM2A, IL6ST, GPRASP1, GNG11, FOXP2, DPYD, DPY19L2P2, DMD, DCN, CXorf57, CIRBP, CHGB, CELF2, CDC14A, BNC2, ARMCX1, ALDH1A1, ABCA8, ABCA5, AASS

  1. A total of 171 DEGs were identified from the four gene expression profiles, including 114 upregulated DEGs and 57 downregulated DEGs in OC tissues compared to normal tissues